| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $109.2M | +1556.8% |
| R&D Expense | $95.7M | -10.8% |
| SG&A Expense | $24.0M | -27.6% |
| Operating Income | -$17.3M | +87.5% |
| Pre-tax Income | -$9.6M | +92.3% |
| Income Tax | -$68K | -103.8% |
| Net Income | -$9.6M | +92.4% |
| EPS (Basic) | -$0.14 | +91.3% |
| EPS (Diluted) | -$0.14 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $61.9M | +5.8% |
| Short-term Investments | $55.3M | -57.8% |
| Current Assets | $120.8M | -37.8% |
| Total Assets | $223.7M | -36.7% |
| Current Liabilities | $20.2M | -84.4% |
| Total Liabilities | $64.8M | -66.2% |
| Stockholders' Equity | $158.9M | -1.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$103.9M | +5.7% |
| Capital Expenditures | $848K | +450.6% |
| Investing Cash Flow | $107.5M | +126.4% |
| Financing Cash Flow | $173K | -99.8% |
| Free Cash Flow | -$104.7M | +5.0% |
| +91.3% |